Go Pro
NYSEAMERICAN:DSS

DSS Q3 2025 Earnings Report

DSS logo
$0.64 -0.01 (-1.88%)
Closing price 10/2/2026 04:10 PM Eastern
Extended Trading
$0.64 0.00 (-0.28%)
As of 10/2/2026 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

DSS EPS Results

Actual EPS
-$0.25
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

DSS Revenue Results

Actual Revenue
$6.39 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

DSS Announcement Details

Quarter
Q3 2025
Time
Before Market Opens
Conference Call Date
Friday, November 14, 2025
Conference Call Time
4:00PM ET

Upcoming Earnings

DSS' Q3 2026 earnings is estimated for Monday, October 26, 2026, based on past reporting schedules

Earnings Documents

DSS Earnings Headlines

Your book attached
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link. He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing.tc pixel
DSS charges woman with food stamp fraud
DSS secures death sentence for Sokoto kidnapper
See More DSS Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like DSS? Sign up for Earnings360's daily newsletter to receive timely earnings updates on DSS and other key companies, straight to your email.

About DSS

DSS (NYSEAMERICAN:DSS) is a diversified holding company formerly known as Document Security Systems, Inc. The company originally focused on anti-counterfeiting and document-security technologies, including solutions designed to protect printed materials and help authenticate documents and products.

Over time, DSS has expanded beyond its original security business through investments in and ownership of companies operating in areas such as packaging, direct marketing, biotechnology and healthcare. Its portfolio has included businesses involved in secure and specialty packaging, digital and direct-response marketing, and the development or commercialization of biotechnology-related products and services.

DSS conducts business through subsidiaries and investments serving customers and partners in the United States and, where applicable, international markets. Because its operations have evolved through acquisitions and portfolio changes, the company’s business mix may vary over time. DSS is headquartered in Rochester, New York.

View DSS Profile